HI
UTHR icon

Harbour Investments’s United Therapeutics UTHR Stock Holding History

Harbour Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.4K Buy
91
+18
+25% +$10.1K ﹤0.01% 2408
2026
Q1 		$43.3K Buy
73
+9
+14% +$4.48K ﹤0.01% 2421
2025
Q4 		$31.2K Buy
64
+2
+3% +$931 ﹤0.01% 2196
2025
Q3 		$26K Buy
62
+2
+3% +$673 ﹤0.01% 2214
2025
Q2 		$17.2K Hold
60
– – ﹤0.01% 2299
2025
Q1 		$18.5K Sell
60
-2
-3% -$685 ﹤0.01% 2212
2024
Q4 		$21.9K Buy
62
+1
+2% +$368 ﹤0.01% 2089
2024
Q3 		$21.9K Buy
61
+1
+2% +$338 ﹤0.01% 2017
2024
Q2 		$19.1K Buy
60
+22
+58% +$5.82K ﹤0.01% 1972
2024
Q1 		$8.73K Hold
38
– – ﹤0.01% 2280
2023
Q4 		$8.36K Buy
38
+2
+6% +$461 ﹤0.01% 2217
2023
Q3 		$8.13K Hold
36
– – ﹤0.01% 2108
2023
Q2 		$7.95K Buy
36
+1
+3% +$222 ﹤0.01% 2137
2023
Q1 		$7.84K Hold
35
– – ﹤0.01% 2121
2022
Q4 		$9.73K Buy
35
+20
+133% +$5.05K ﹤0.01% 1964
2022
Q3 		$4K Hold
15
– – ﹤0.01% 2271
2022
Q2 		$4K Buy
+15
New +$3.05K ﹤0.01% 2271
2021
Q4 		– Sell
-140
Closed -$26K – 3655
2021
Q3 		$26K Sell
140
-62
-31% -$12.2K ﹤0.01% 2165
2021
Q2 		$36K Buy
202
+32
+19% +$6.09K ﹤0.01% 1996
2021
Q1 		$29K Buy
+170
New +$28.3K ﹤0.01% 1997

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Harbour Investments's UTHR Position: Q2 2026 in Review

Harbour Investments increased its United Therapeutics (UTHR) stake by 25% in Q2 2026, buying an estimated $10.1K and bringing the position to 91 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Harbour Investments first reported a position in UTHR in Q1 2021 and has held it in 20 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Harbour Investments held 91 shares of United Therapeutics worth $49.4K as of Q2 2026.
  • Harbour Investments bought 18 United Therapeutics shares in Q2 2026, an estimated $10.1K.
  • United Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2408 holding.
  • Harbour Investments first reported a position in United Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.